(Q38492736)

3 September 2017

Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance (English)

1 reference

3 September 2017

1 reference

Hedley DW

1

1 reference

PubMed ID

4017799

3 September 2017

Friedlander ML

series ordinal

2

1 reference

PubMed ID

4017799

3 September 2017

Taylor IW

series ordinal

3

1 reference

3 September 2017

1 July 1985

1 reference

3 September 2017

7

1 reference

inferred from page(s)

published in

Cytometry

1 reference

3 September 2017

6

1 reference

3 September 2017

327-333

1 reference

3 September 2017

4

1 reference

Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases

3 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

Cellular DNA content--a stable feature in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

An evaluation of DNA fluorochromes, staining techniques, and analysis for flow cytometry. I. Unperturbed cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

Modal Deoxyribonucleic Acid Value and Survival in Carcinoma of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Clinical and biological significance of aneuploidy in human tumours

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Cell proliferation and its relationship to clinical features and relapse in breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Metastatic adenocarcinoma of unknown primary site: abnormalities of cellular DNA content and survival.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Steroid-hormone receptors and survival after first relapse in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Ploidy Level of Human Breast Carcinoma Relation to Histopathologic Features and Hormone Receptor Content

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Prediction of early course of breast carcinoma by thymidine labeling

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Ploidy, proliferative activity and estrogen receptor content in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Unknown primary adenocarcinoma: incidence of overinvestigation and natural history

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

The influence of age on the DNA ploidy levels of breast tumours

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

The long-term prognostic significance of the thymidine labelling index in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060409

7 January 2021

Identifiers

DOI

10.1002/CYTO.990060409

1 reference

3 September 2017

1 reference

PubMed ID

4017799